105 related articles for article (PubMed ID: 20520543)
1. Supportive care in children.
Santolaya ME
Curr Opin Oncol; 2010 Jul; 22(4):323-9. PubMed ID: 20520543
[TBL] [Abstract][Full Text] [Related]
2. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
Santolaya ME
Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
[TBL] [Abstract][Full Text] [Related]
3. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Clin Infect Dis; 2002 Sep; 35(6):678-83. PubMed ID: 12203164
[TBL] [Abstract][Full Text] [Related]
5. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
[TBL] [Abstract][Full Text] [Related]
6. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
[TBL] [Abstract][Full Text] [Related]
7. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
te Poele EM; Tissing WJ; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
[TBL] [Abstract][Full Text] [Related]
9. Evolving concepts of management of febrile neutropenia in children with cancer.
Orudjev E; Lange BJ
Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
11. Advances in management of low-risk febrile neutropenia.
Teuffel O; Sung L
Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
[TBL] [Abstract][Full Text] [Related]
12. Approach to treatment of the febrile cancer patient with low-risk neutropenia.
Buchanan GR
Hematol Oncol Clin North Am; 1993 Oct; 7(5):919-35. PubMed ID: 8226566
[TBL] [Abstract][Full Text] [Related]
13. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
14. Management of the febrile neutropenic cancer patient: lessons from 40 years of study.
Bow EJ
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():24-9. PubMed ID: 16138816
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
16. Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.
Dubos F; Delebarre M; Martinot A
Curr Opin Hematol; 2012 Jan; 19(1):39-43. PubMed ID: 22123661
[TBL] [Abstract][Full Text] [Related]
17. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
18. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
Carstensen M; Sørensen JB
J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
[TBL] [Abstract][Full Text] [Related]
19. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
20. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
